Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Tandem Diabetes Care, Inc. produces medical devices. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Tandem Diabetes Care offers its products to the medical industries in the United States.
Website: tandemdiabetes.com



Growth: Pretty weak revenue growth rate 2.0%, there is slowdown compared to average historical growth rates 9.4%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +47.9%

Profitability: LTM EBITDA margin is negative, -17.9%. On average the margin is improving steadily. Gross margin is high, +53.9%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 0% of quarters (showing a gain of -$0.54 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -9.8% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 99.7% higher than minimum and 62.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.0x by EV / Sales multiple , the company can be 29.8% overvalued

Key Financials (Download financials)

Ticker: TNDM
Share price, USD:  (0.0%)20.2
year average price 18.58  


year start price 36.10 2025-02-08

max close price 36.10 2025-02-08

min close price 10.12 2025-08-11

current price 20.20 2026-02-07
Common stocks: 64 146 000

Dividend Yield:  0.0%
EV / Sales: 1.4x
Margin (EBITDA LTM / Revenue): -17.9%
Fundamental value created in LTM:
Market Cap ($m): 1 296
Net Debt ($m): 130
EV (Enterprise Value): 1 426
Price to Book: 9.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-07prnewswire.com

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-02-05globenewswire.com

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

2026-02-01newsfilecorp.com

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-01-31prnewswire.com

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-01-30globenewswire.com

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

2026-01-29newsfilecorp.com

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-01-26prnewswire.com

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-01-24newsfilecorp.com

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-01-22newsfilecorp.com

TNDM INVESTOR NEWS: ROSEN, A LONGSTANDING FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

2026-01-21prnewswire.com

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-06 2024-11-06 2024-08-01 2024-05-02 2023-11-01 2023-08-03 2023-05-03 2022-11-02
acceptedDate 2025-11-06 16:15:27 2025-08-06 16:23:50 2025-02-26 16:09:22 2024-11-06 16:11:29 2024-08-01 16:11:56 2024-05-02 16:12:19 2024-02-21 16:33:22 2023-11-01 16:08:59 2023-08-03 16:08:39 2023-05-03 16:12:27 2023-02-22 16:08:52 2022-11-02 16:09:13 2022-02-22 16:11:09 2021-02-24 16:12:08
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 249M 241M 940M 363M 222M 192M 748M 186M 196M 169M 801M 205M 703M 499M
costOfRevenue 115M 115M 451M 239M 109M 97M 380M 96M 94M 86M 388M 100M 327M 238M
grossProfit 134M 126M 490M 125M 113M 95M 368M 90M 102M 83M 413M 104M 376M 261M
grossProfitRatio 0.539 0.523 0.343 0.508 0.494 0.484 0.519 0.489 0.511
researchAndDevelopmentExpenses 48M 48M 199M 51M 49M 46M 248M 42M 43M 42M 170M 68M 92M 64M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 106M 110M 390M 100M 94M 90M 353M 79M 98M 90M 336M 84M 262M 205M
otherExpenses 0 20M 0 0 0 0 0 816 000 0 4M 0 0 0 0
operatingExpenses 154M 178M 589M 151M 144M 136M 601M 121M 141M 132M 506M 152M 354M 268M
costAndExpenses 269M 292M 1 039M 389M 253M 233M 981M 217M 235M 218M 894M 252M 680M 507M
interestIncome 0 0 18M 5M 3M 5M 23M 6M 6M 6M 6M 2M 674 000 2M
interestExpense 2M 3M 7M 2M 2M 1M 10M -5M 2M -2M 6M 1M 6M 13M
depreciationAndAmortization 4M 4M 158 000 4M 4M 4M 16M 4M 4M 76M 14M 5M 14M 10M
ebitda -19M -51M -99M -17M -24M -38M -196M -32M -29M 30M -74M -43M 34M -13M
ebitdaratio -0.075 -0.211 -0.046 -0.12 -0.196 -0.17 -0.147 0.175 -0.209
operatingIncome -20M -52M -99M -26M -31M -42M -233M -32M -39M -46M -93M -47M 23M -8M
operatingIncomeRatio -0.08 -0.215 -0.072 -0.139 -0.217 -0.17 -0.198 -0.274 -0.232
totalOtherIncomeExpensesNet -5M -6M 7M 3M 1M 2M 13M 816 000 4M -77M -4000 144 000 -7M -28M
incomeBeforeTax -25M -58M -92M -23M -30M -40M -220M -31M -35M -124M -93M -47M 16M -36M
incomeBeforeTaxRatio -0.101 -0.24 -0.062 -0.134 -0.206 -0.166 -0.177 -0.73 -0.231
incomeTaxExpense -4M -5M 4M 637 000 1M 3M 2M 2M 1M 287 000 2M 2M 335 000 -2M
netIncome -21M -52M -96M -23M -31M -43M -223M -33M -36M -124M -95M -49M 16M -34M
netIncomeRatio -0.085 -0.218 -0.064 -0.139 -0.223 -0.178 -0.183 -0.731 -0.239
eps -0.31 -0.78 -1.47 -0.35 -0.47 -0.65 -3.43 -0.51 -0.55 -1.92 -1.47 -0.76 0.25 -0.56
epsdiluted -0.31 -0.78 -0.35 -0.47 -0.65 -0.51 -0.55 -1.92 -0.76
weightedAverageShsOut 68M 67M 65M 66M 65M 65M 65M 65M 65M 65M 64M 64M 63M 61M
weightedAverageShsOutDil 68M 67M 65M 66M 65M 65M 65M 65M 65M 65M 64M 64M 64M 61M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-26 2024-02-21 2023-02-22 2022-02-22 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 11M 13M -151 000 -5M -11M
ebit -99M -212M -89M 20M -23M
nonOperatingIncomeExcludingInterest 158 000 -21M -4M 2M 16M
netIncomeFromContinuingOperations -96M -223M -95M 16M -34M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -96M -223M -95M 16M -34M
epsDiluted -1.47 -3.43 -1.47 0.24 -0.56

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-06 2024-11-06 2024-08-01 2024-05-02 2023-11-01 2023-08-03 2023-05-03 2022-11-02
acceptedDate 2025-11-06 16:15:27 2025-08-06 16:23:50 2025-02-26 16:09:22 2024-11-06 16:11:29 2024-08-01 16:11:56 2024-05-02 16:12:19 2024-02-21 16:33:22 2023-11-01 16:08:59 2023-08-03 16:08:39 2023-05-03 16:12:27 2023-02-22 16:08:52 2022-11-02 16:09:13 2022-02-22 16:11:09 2021-02-24 16:12:08
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 92M 64M 69M 49M 48M 59M 59M 80M 131M 128M 173M 124M 71M 95M
shortTermInvestments 227M 251M 369M 424M 405M 409M 409M 419M 376M 392M 444M 485M 553M 390M
cashAndShortTermInvestments 319M 315M 438M 473M 452M 468M 468M 498M 507M 520M 617M 609M 624M 485M
netReceivables 126M 128M 115M 107M 98M 93M 106M 100M 99M 91M 115M 113M 111M 82M
inventory 137M 143M 150M 152M 162M 154M 158M 143M 148M 132M 111M 105M 69M 64M
otherCurrentAssets 35M 28M 22M 20M 21M 21M 17M 16M 11M 15M 7M 8M 0 0
totalCurrentAssets 617M 615M 724M 753M 733M 735M 748M 758M 764M 758M 850M 834M 812M 637M
propertyPlantEquipmentNet 176M 176M 163M 168M 167M 166M 164M 165M 165M 179M 179M 189M 78M 70M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 925 000 0 0 0 3M 0 0 0 5M 0 7M 9M
goodwillAndIntangibleAssets 0 0 925 000 0 0 0 3M 0 0 0 5M 0 7M 9M
longTermInvestments 65M 68M 75M 0 30M 10M 0 10M 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 17M 17M 4M 36M 7M 30M 38M 6M 18M 17M 19M 24M 9M 580 000
totalNonCurrentAssets 258M 261M 243M 205M 204M 206M 205M 182M 182M 196M 203M 213M 94M 79M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 875M 876M 968M 958M 938M 941M 953M 940M 947M 954M 1 053M 1 048M 905M 716M
accountPayables 47M 56M 45M 49M 48M 48M 50M 46M 57M 55M 56M 62M 28M 18M
shortTermDebt 21M 20M 41M 59M 58M 17M 0 18M 18M 16M 0 12M 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 10M 11M 12M 43M 44M 45M 44M 32M 23M 21M 19M 13M 10M 6M
otherCurrentLiabilities 174M 165M 47M 109M 90M 83M 72M 92M 76M 79M 68M 87M 75M 66M
totalCurrentLiabilities 253M 252M 247M 259M 241M 193M 195M 187M 175M 171M 165M 174M 132M 104M
longTermDebt 428M 429M 308M 417M 419M 347M 285M 401M 403M 405M 283M 410M 281M 203M
deferredRevenueNonCurrent 9M 10M 10M 11M 12M 12M 13M 14M 15M 16M 17M 19M 17M 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 111M 113M 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 52M 52M 32M 32M 32M 32M 32M 24M 25M 24M 24M 365M 18M 27M
totalNonCurrentLiabilities 489M 491M 458M 461M 463M 505M 444M 439M 443M 444M 448M 452M 340M 246M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 118M 140M 125M 128M 129M 113M 131M 134M 136M 137M 137M 139M 33M 25M
totalLiabilities 742M 742M 705M 720M 704M 698M 639M 626M 617M 615M 613M 626M 472M 350M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 68 000 68 000 66 000 66 000 65 000 65 000 66 000 65 000 65 000 65 000 65 000 64 000 64 000 62 000
retainedEarnings -1 252M -1 231M -1 048M -1 049M -1 025M -995M -952M -922M -889M -853M -729M -713M -635M -659M
accumulatedOtherComprehensiveIncomeLoss 5M 4M -2M 4M -1M -935 000 1M -2M -1M -93 000 -2M -5M -616 000 220 000
othertotalStockholdersEquity 1 380M 1 360M 1 282M 1 260M 1 238M 1 238M 1 219M 1 192M 1 140M
totalStockholdersEquity 133M 133M 263M 238M 234M 243M 314M 314M 329M 339M 440M 422M 433M 366M
totalEquity 133M 133M 263M 238M 234M 243M 314M 314M 329M 339M 440M 422M 433M 366M
totalLiabilitiesAndStockholdersEquity 875M 876M 958M 938M 941M 940M 947M 954M 1 048M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 875M 876M 968M 958M 938M 941M 953M 940M 947M 954M 1 053M 1 048M 905M 716M
totalInvestments 292M 319M 444M 424M 435M 419M 409M 419M 376M 392M 444M 485M 553M 390M
totalDebt 449M 449M 474M 476M 477M 478M 416M 418M 420M 420M 420M 422M 315M 228M
netDebt 357M 385M 404M 427M 429M 419M 357M 339M 290M 293M 247M 298M 243M 134M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-26 2024-02-21 2023-02-22 2022-02-22 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 115M 106M 115M 111M 82M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 8M 6M
totalPayables 45M 50M 56M 28M 18M
otherPayables 0 0 0 0 0
accruedExpenses 85M 13M 10M 9M 5M
capitalLeaseObligationsCurrent 18M 17M 13M 9M 9M
capitalLeaseObligationsNonCurrent 106M 114M 124M 24M 16M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 313M 1 264M 1 171M 1 068M 1 025M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM TNDM
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-06 2024-11-06 2024-08-01 2024-05-02 2023-11-01 2023-08-03 2023-05-03 2022-11-02
acceptedDate 2025-11-06 16:15:27 2025-08-06 16:23:50 2025-02-26 16:09:22 2024-11-06 16:11:29 2024-08-01 16:11:56 2024-05-02 16:12:19 2024-02-21 16:33:22 2023-11-01 16:08:59 2023-08-03 16:08:39 2023-05-03 16:12:27 2023-02-22 16:08:52 2022-11-02 16:09:13 2022-02-22 16:11:09 2021-02-24 16:12:08
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -21M -52M -96M -23M -31M -43M -223M -33M -36M -124M -95M -49M 16M -34M
depreciationAndAmortization 4M 4M 17M 4M 4M 4M 16M 4M 4M 3M 14M 4M 14M 10M
deferredIncomeTax 0 0 0 0 0 0 0 -20M 17M 0 0 0 0 -2M
stockBasedCompensation 21M 26M 101M 26M 25M 22M 88M 21M 23M 21M 85M 22M 61M 58M
changeInWorkingCapital -3M 9M -12M 15M -8M 5M -18M 6M -15M -88 000 -5M 14M 14M -37M
accountsReceivables -1M -3M -21M -12M -7M 10M 4M -4M -9M 23M -8M -10M -31M -39M
inventory 5M 2M 6M 10M -8M 3M -46M 3M -16M -20M -42M -17M -5M -15M
accountsPayables -9M 0 -2M -1M 4M -3M -5M -9M 11M -919 000 24M 0 10M 1M
otherWorkingCapital 3M 9M 6M 18M 3M -5M 29M 15M -480 000 -2M 21M 40M 40M 16M
otherNonCashItems 7M 4M 14M 5M 50M 24M 105M 23M 110 000 81M 50M 33M 7M 29M
netCashProvidedByOperatingActivities 8M -9M 24M 27M -5M -8M -32M 55 000 -6M -18M 50M 24M 111M 25M
investmentsInPropertyPlantAndEquipment -4M -6M -19M -5M -6M -4M -27M -5M -10M -9M -34M -22M -14M -27M
acquisitionsNet 0 0 0 0 0 0 -69M 43M 2M -71M -26M 0 0 0
purchasesOfInvestments -30M -17M -264M -74M -93M -84M -536M -156M -126M -109M -468M -133M -733M -497M
salesMaturitiesOfInvestments 54M 81M 306M 59M 96M 84M 546M 112M 140M 163M 569M 166M 570M 233M
otherInvestingActivites 0 0 0 3M -599 000 -43M 0 0 -34M
netCashUsedForInvestingActivites 21M 58M -20M -4M -5M -49M 6M -26M -14M
debtRepayment 0 -41M 0 9M -45M 0 0 0 0
commonStockIssued -2M 0 -5M -3M -2M -2M 0 -541 000 0
commonStockRepurchased 0 0 -30M 3M -3M -30M 0 -2M 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 1M -5M -12M 183 000 2M 0 0 -774 000
netCashUsedProvidedByFinancingActivities -2M -40M -5M -3M 14M -2M 4M -541 000 -774 000
effectOfForexChangesOnCash 605 002 2M 1M -1M 535 000 -423 000 -212 000 -759 000 -334 000 441 000 827 000 -186 000 153 000 387 000
netChangeInCash 28M 11M 10M 1M -11M 111 000 -114M -51M 3M -45M 101M 9M -23M 43M
cashAtEndOfPeriod 92M 64M 69M 49M 48M 59M 59M 80M 131M 128M 173M 124M 71M 95M
cashAtBeginningOfPeriod 64M 54M 59M 48M 59M 59M 173M 131M 128M 173M 71M 115M 95M 51M
operatingCashFlow 8M -9M 24M 27M -5M -8M -32M 55 000 -6M -18M 50M 24M 111M 25M
capitalExpenditure -4M -6M -19M -5M -6M -4M -27M -5M -10M -9M -34M -22M -24M -32M
freeCashFlow 4M -16M 5M 22M -12M -12M -59M -5M -16M -27M 16M 2M 88M -8M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-26 2024-02-21 2023-02-22 2022-02-22 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -46M 0 -9M -9M -5M
netCashProvidedByInvestingActivities -23M -86M 33M -187M -296M
netDebtIssuance 45M 0 0 0 279M
longTermNetDebtIssuance 45M 0 0 0 279M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -37M 0 18M 0 0
netCommonStockIssuance -37M 0 18M 0 0
commonStockIssuance -7M 0 18M 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 183 000 4M -675 000 52M 36M
netCashProvidedByFinancingActivities 8M 4M 17M 52M 314M
incomeTaxesPaid 0 2M 0 260 000 177 000
interestPaid 0 8M 0 4M 3M

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-08-07 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-27 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-02 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-21 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-22 ET (fiscal 2022 q4)
2022 q3
2022-11-02 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-06 16:15 ET
Tandem Diabetes Care reported for 2025 q3
SEC form 8
2025-11-06 16:09 ET
Tandem Diabetes Care published news for 2025 q3
SEC form 8
2025-11-06 16:09 ET
Tandem Diabetes Care reported for 2025 q3
SEC form 10
2025-08-06 20:23 ET
Tandem Diabetes Care reported for 2025 q2
SEC form 8
2025-08-06 20:17 ET
Tandem Diabetes Care published news for 2025 q2
SEC form 8
2025-08-06 20:17 ET
Tandem Diabetes Care reported for 2025 q2
SEC form 10
2025-04-30 20:11 ET
Tandem Diabetes Care published news for 2025 q1
SEC form 10
2025-04-30 00:00 ET
Tandem Diabetes Care published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Tandem Diabetes Care published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Tandem Diabetes Care reported for 2025 q1
SEC form 10
2025-02-26 21:09 ET
Tandem Diabetes Care published news for 2024 q4
SEC form 10
2025-02-26 00:00 ET
Tandem Diabetes Care reported for 2024 q4
SEC form 8
2025-02-26 00:00 ET
Tandem Diabetes Care published news for 2024 q4
SEC form 8
2025-02-26 00:00 ET
Tandem Diabetes Care reported for 2024 q4
SEC form 10
2024-11-06 16:11 ET
Tandem Diabetes Care published news for 2024 q3
SEC form 8
2024-11-06 16:08 ET
Tandem Diabetes Care published news for 2024 q3
SEC form 8
2024-11-06 16:08 ET
Tandem Diabetes Care published news for 2024 q3
SEC form 10
2024-08-01 16:11 ET
Tandem Diabetes Care reported for 2024 q2
SEC form 8
2024-08-01 16:07 ET
Tandem Diabetes Care published news for 2024 q2
SEC form 8
2024-08-01 16:07 ET
Tandem Diabetes Care reported for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Tandem Diabetes Care published news for 2024 q2
SEC form 10
2024-05-02 16:12 ET
Tandem Diabetes Care published news for 2024 q1
SEC form 8
2024-05-02 16:07 ET
Tandem Diabetes Care published news for 2024 q1
SEC form 8
2024-05-02 16:07 ET
Tandem Diabetes Care reported for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Tandem Diabetes Care published news for 2024 q1
SEC form 10
2024-02-21 16:33 ET
Tandem Diabetes Care published news for 2023 q4
SEC form 8
2024-02-21 16:09 ET
Tandem Diabetes Care published news for 2023 q4
SEC form 8
2024-02-21 16:09 ET
Tandem Diabetes Care reported for 2023 q4
SEC form 10
2024-02-21 00:00 ET
Tandem Diabetes Care published news for 2023 q4
SEC form 10
2023-11-01 16:08 ET
Tandem Diabetes Care reported for 2023 q3
SEC form 8
2023-11-01 16:03 ET
Tandem Diabetes Care published news for 2023 q3
SEC form 10
2023-11-01 00:00 ET
Tandem Diabetes Care published news for 2023 q3
SEC form 10
2023-08-03 16:08 ET
Tandem Diabetes Care reported for 2023 q2
SEC form 6
2023-08-03 16:04 ET
Tandem Diabetes Care published news for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Tandem Diabetes Care published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Tandem Diabetes Care published news for 2023 q2
SEC form 10
2023-05-03 00:00 ET
Tandem Diabetes Care published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Tandem Diabetes Care published news for 2023 q1
SEC form 6
2023-02-22 16:20 ET
Tandem Diabetes Care published news for 2022 q4
SEC form 10
2023-02-22 16:08 ET
Tandem Diabetes Care reported for 2022 q4
SEC form 10
2023-02-22 00:00 ET
Tandem Diabetes Care reported for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Tandem Diabetes Care reported for 2022 q4
SEC form 6
2023-01-23 09:05 ET
Tandem Diabetes Care published news for 2022 q4
SEC form 6
2023-01-10 16:09 ET
Tandem Diabetes Care published news for 2022 q4
SEC form 8
2023-01-10 00:00 ET
Tandem Diabetes Care published news for 2022 q4
SEC form 6
2022-12-13 06:35 ET
Tandem Diabetes Care published news for 2022 q3
SEC form 6
2022-11-17 18:51 ET
Tandem Diabetes Care published news for 2022 q3
SEC form 10
2022-11-02 16:09 ET
Tandem Diabetes Care reported for 2022 q3
SEC form 6
2022-11-02 16:07 ET
Tandem Diabetes Care published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
Tandem Diabetes Care reported for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Tandem Diabetes Care reported for 2022 q3
SEC form 10
2022-08-03 16:11 ET
Tandem Diabetes Care reported for 2022 q2
SEC form 6
2022-08-03 16:08 ET
Tandem Diabetes Care published news for 2022 q2
SEC form 10
2022-08-03 00:00 ET
Tandem Diabetes Care reported for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Tandem Diabetes Care reported for 2022 q2
SEC form 6
2022-07-12 18:40 ET
Tandem Diabetes Care published news for 2022 q2
SEC form 6
2022-06-17 18:38 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-06-16 11:53 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-27 21:37 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-27 16:38 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-19 20:08 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-19 20:05 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-19 19:58 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-19 19:25 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-19 19:14 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-18 19:20 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-18 19:11 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-18 19:09 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-18 18:27 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-18 18:25 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-10 18:45 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-10 18:33 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-10 18:23 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-10 17:01 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-05-04 17:04 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 10
2022-05-04 16:15 ET
Tandem Diabetes Care reported for 2022 q1
SEC form 6
2022-05-04 16:11 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 10
2022-05-04 00:00 ET
Tandem Diabetes Care reported for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Tandem Diabetes Care reported for 2022 q1
SEC form 6
2022-04-13 16:27 ET
Tandem Diabetes Care published news for 2022 q1
SEC form 6
2022-03-30 17:11 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 6
2022-03-15 17:14 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 10
2022-02-22 16:11 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 6
2022-02-22 16:07 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 10
2022-02-22 00:00 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 6
2022-02-16 08:33 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 6
2022-02-03 16:42 ET
Tandem Diabetes Care published news for 2021 q4
SEC form 6
2021-11-24 16:22 ET
Tandem Diabetes Care published news for 2021 q3
SEC form 10
2021-11-03 16:13 ET
Tandem Diabetes Care published news for 2021 q3
SEC form 6
2021-11-03 16:05 ET
Tandem Diabetes Care published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
Tandem Diabetes Care published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
Tandem Diabetes Care published news for 2021 q3
SEC form 6
2021-09-17 17:04 ET
Tandem Diabetes Care published news for 2021 q2
SEC form 10
2021-08-04 16:11 ET
Tandem Diabetes Care published news for 2021 q2
SEC form 6
2021-08-04 16:05 ET
Tandem Diabetes Care published news for 2021 q2
SEC form 10
2021-08-04 00:00 ET
Tandem Diabetes Care published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
Tandem Diabetes Care published news for 2021 q2
SEC form 6
2021-06-10 16:55 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-06-10 16:55 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-21 13:10 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:38 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:36 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:35 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:34 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:34 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:29 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:25 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:10 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-20 21:08 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-19 17:11 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 10
2021-05-05 16:13 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-05-05 16:10 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 10
2021-05-05 00:00 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-04-23 18:30 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-04-07 16:15 ET
Tandem Diabetes Care published news for 2021 q1
SEC form 6
2021-03-17 17:52 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 6
2021-03-12 20:42 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 6
2021-03-03 19:32 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 10
2021-02-24 16:12 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 6
2021-02-24 16:09 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 6
2021-02-08 16:06 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 6
2021-01-05 16:49 ET
Tandem Diabetes Care published news for 2020 q4
SEC form 6
2020-12-14 16:10 ET
Tandem Diabetes Care published news for 2020 q3
SEC form 6
2020-11-23 16:10 ET
Tandem Diabetes Care published news for 2020 q3
SEC form 10
2020-11-05 16:15 ET
Tandem Diabetes Care published news for 2020 q3
SEC form 6
2020-11-05 16:11 ET
Tandem Diabetes Care published news for 2020 q3